Dendreon Company
Dendreon was a biotechnology company produces immunotherapy for prostate cancer.
Technology:
Atrificial Vectors and Immune Cells, Cell therapy
Industry:
Atrificial Vectors and Immune Cells, Delisted
Headquarters:
Seattle, Washington, United States
Founded Date:
1992-01-01
Employees Number:
1001-5000
Funding Status:
M&A
Register and Claim Ownership